Phenytoin是一种失活的电压门控钠离子通道稳定剂。
Phenytoin is an inactive voltage-gated sodium channel stabilizer.
动物 A (mg/kg) = 动物 B (mg/kg)×动物 B的Km系数/动物 A的Km系数 | |
例如,已知某工具药用于小鼠的剂量为88 mg/kg , 则用于大鼠的剂量换算方法:将88 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到该药物用于大鼠的等效剂量44 mg/kg。
[1] Ji Hyun Yi et. Al. Genetic Variations of ABCC2 Gene Associated with Adverse Drug Reactions to Valproic Acid in Korean Epileptic Patients. Genomics & Informatics, 11(4), 254-262 (2013).
[2] Yasuo Uchida et. Al. Pharmacoproteomics-based reconstruction of in vivo P-glycoprotein function at blood-brain barrier and brain distribution of substrate verapamil in pentylenetetrazole-kindled epilepsy, spontaneous epilepsy, and phenytoin treatment models. Drug Metabolism and Disposition, 42(10), 1719-1726 (2014).
[3] David S Paek et. Al. Metyrapone alleviates deleterious effects of maternal food restriction on lung development and growth of rat offspring. Reproductive Sciences, 22(2), 207-222 (2015).
分子式 C15H12N2O2 |
分子量 252.27 |
CAS号 57-41-0 |
储存方式 ﹣20 ℃冷藏长期储存。冰袋运输 |
溶剂(常温) |
DMSO 50 mg/mL |
Water <1 mg/mL |
Ethanol 12 mg/mL |
体内溶解度
NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
NCT00581893 | Cognitive Measures|Driving Simulator Performance | Drug: Phenytoin | University of Iowa | Phase 4 | 2005-08-01 | 2007-12-27 |
NCT02413658 | Wound|Re-Epithelialization | Drug: Phenytoin|Drug: Sugar solution | Children's Surgical Center, Cambodia | Phase 2 | 2015-03-01 | 2015-04-09 |
NCT02409433 | Seizures | Drug: lacosamide|Drug: Phenytoin | Lawson Health Research Institute|UCB Pharma GmbH | Phase 4 | 2014-08-01 | 2016-01-05 |
NCT00823264 | Phenytoin Toxicity | Drug: Activated Charcoal | Emory University | 2008-08-01 | 2014-09-04 | |
NCT01122940 | Healthy | Drug: Epamin: Reference Drug|Drug: Phenytoin: Study Drug | Pfizer | Phase 1 | 2010-07-01 | 2011-01-13 |
NCT01478035 | Seizures|Pneumococcal Meningitis | Drug: Phenytoin|Drug: placebo | M. Carmen Cabellos Minguez|Hospital Universitari de Bellvitge|Hospital Vall d'Hebron|Germans Trias i Pujol Hospital|Hospital Clinic of Barcelona|Fundaci贸 Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau|Hospitales Universitarios Virgen del Roco|Hospital Universitario La Paz|Hospital Universitario Ramon y Cajal|Hospital Juan Canalejo|Hospital Mutua de Terrassa|Hospital Universitario Virgen Macarena | Phase 4 | 2011-11-01 | 2012-12-19 |
NCT01187719 | HIV-infection|Pregnancy|Mother to Child Transmission | Drug: phenytoin | Radboud University | Phase 2 | 2010-05-01 | 2012-09-17 |
NCT01451593 | Optic Neuritis|Multiple Sclerosis | Drug: Phenytoin|Drug: Placebo | University College, London|National Multiple Sclerosis Society|Multiple Sclerosis Society of Great Britain and Northern Ireland | Phase 2 | 2011-11-01 | 2015-09-08 |
NCT02939937 | Optic Neuritis | Drug: Phenytoin|Drug: placebo | Tehran University of Medical Sciences | Phase 2 | 2016-07-01 | 2016-10-18 |
NCT01122953 | Healthy | Drug: Phenytoin|Drug: Epamin | Pfizer | Phase 1 | 2010-04-01 | 2010-07-15 |
NCT02595723 | Cognitive Impairment | Drug: Phenytoin|Drug: Megestrol Acetate|Drug: Placebo | University of Texas Southwestern Medical Center|The Rogosin Institute | Early Phase 1 | 2015-07-01 | 2016-12-28 |
NCT00146237 | Depression | Drug: phenytoin | Beersheva Mental Health Center|The Rogosin Institute | Phase 4 | 2003-11-01 | 2009-11-23 |
NCT01680042 | Wound Healing|Pain | Drug: Phenytoin paste|Drug: Placebo | Shahid Beheshti University of Medical Sciences | Phase 1 | 2012-10-01 | 2012-10-01 |
NCT02088957 | Nonconvulsive Electrographic Seizures | Drug: Brivaracetam intravenous solution|Drug: Brivaracetam oral tablets|Drug: Phenytoin intravenous solution|Drug: Phenytoin oral tablets | UCB BIOSCIENCES, Inc.|PRA Health Sciences|UCB Pharma | Phase 2 | 2014-03-01 | 2016-07-05 |
NCT00366067 | Bronchial Asthma | Drug: Phenytoin | Centre of Chinese Medicine, Georgia|Rea Rehabilitation Centre, Georgia | Phase 4 | 2006-08-01 | 2009-02-18 |
NCT00426673 | Epilepsy | Drug: Brivaracetam (ucb34714) | UCB Pharma | Phase 1 | 2005-04-01 | 2008-03-07 |
NCT00591006 | Healthy | Drug: Phenytoin (brand name Dilantin)|Drug: Hydrocortisone|Drug: Placebo | University of Texas Southwestern Medical Center | Phase 3 | 2008-01-01 | 2015-08-12 |
NCT00162461 | Healthy | Drug: Phenytoin single dose (300 mg) | Hadassah Medical Organization|United States - Israel Binational Science Foundation | 1998-08-01 | 2017-03-03 | |
NCT00647621 | Healthy | Drug: Extended Phenytoin Sodium Capsules 100 mg|Drug: DilantinKapseals 100 mg | Mylan Pharmaceuticals | Phase 1 | 2005-10-01 | 2008-03-31 |
NCT00000285 | Cocaine-Related Disorders | Drug: Phenytoin | National Institute on Drug Abuse (NIDA)|University of Minnesota - Clinical and Translational Science Institute | Phase 1 | 1996-05-01 | 2017-01-11 |
NCT01635829 | Healthy Participants | Drug: Telaprevir|Drug: Phenytoin|Drug: Carbamazepine | Janssen Infectious Diseases BVBA | Phase 1 | 2012-05-01 | 2013-10-23 |
NCT00781196 | Gingival Overgrowth | Drug: folic acid|Drug: placebo | All India Institute of Medical Sciences, New Delhi | Phase 3 | 2008-05-01 | 2009-08-03 |
NCT00219479 | Seizures | Drug: Phenytoin (Dilantin) levels during change in enteral feeding | Penn State University | Phase 4 | 1997-08-01 | 2008-06-13 |
注:以上所有数据均来自公开文献,并不保证对所有实验均有效,数据仅供参考。
相关化合物库
使用AMQUAR产品发表文献后请联系我们